Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps.
Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T, Holtappels G, Tavernier J, van Cauwenberge P, Bachert C.
Gevaert P, et al. Among authors: van zele t, van cauwenberge p.
J Allergy Clin Immunol. 2006 Nov;118(5):1133-41. doi: 10.1016/j.jaci.2006.05.031. Epub 2006 Sep 26.
J Allergy Clin Immunol. 2006.
PMID: 17088140
Clinical Trial.